| A Study of LM-364 as a Single Agent or in Combination With Anti-tumor Therapy in Patients With Advanced Solid Tumors (NCT07694765) | LaNova Medicines Limited | 2026-07-15 |
| Evaluation of XYA02 in Patients With Advanced Solid Tumors (NCT07670312) | XYone Therapeutics, Inc | 2026-07-15 |
| HB-adMSCs for the Treatment of Crohn's Disease (NCT07077746) | Hope Biosciences Research Foundation | 2026-07-14 |
| Safety, Tolerability, and Pharmacokinetics of SVG103 (Paxalisib) in Focal Cortical Dysplasia Type II (FCD-II), Tuberous Sclerosis Complex (TSC) or Hemimegalencephaly (HME) (NCT07287202) | Sovargen | 2026-07-14 |
| A Study of Rocbrutinib in Combination With Lacutoclax in Patients With B-Cell Malignancies (NCT07609862) | Guangzhou Lupeng Pharmaceutical Company LTD. | 2026-07-14 |
| Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection (NCT07383649) | The Methodist Hospital Research Institute | 2026-07-14 |
| Superiority Trial of Aphasia-focused Rehabilitation With tDCS Stimulation (NCT07688551) | University of South Carolina | 2026-07-14 |
| A Study of Rusfertide in Japanese Adults With Polycythemia Vera (NCT07648030) | Takeda | 2026-07-14 |
| A Study of Lacutoclax (LP-108) in Patients With Relapsed/Refractory CLL/SLL (NCT07609823) | Guangzhou Lupeng Pharmaceutical Company LTD. | 2026-07-14 |
| A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment (NCT07293247) | Alliance for Clinical Trials in Oncology | 2026-07-14 |
| Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer (NCT07281768) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2026-07-14 |
| A Research Study to Investigate the Efficacy and Safety of HRS9531 Tablets in Participants With Type 2 Diabetes Mellitus (NCT07599410) | Fujian Shengdi Pharmaceutical Co., Ltd. | 2026-07-14 |
| Early Response-guided Sequential Radiotherapy After Chemoimmunotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma (NCT07721103) | Tianjin Medical University Cancer Institute and Hospital | 2026-07-14 |
| CLEAR (Cervical Lymphatic Exclusion in Adjuvant Radiation) (NCT07755449) | Institut Català d'Oncologia | 2026-07-13 |
| SL-28 for Advanced Solid Tumours (NCT07341737) | Second Life Therapeutics | 2026-07-13 |
| A Study to Learn About How Well the Medicine Efgartigimod Works to Treat Autoimmune Encephalitis In Children 12 Years or Older and Adults (NCT07583641) | argenx | 2026-07-13 |
| An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis (NCT06557733) | National Cancer Institute (NCI) | 2026-07-13 |
| First-in-Human Trial of VBC108 in Participants With Advanced Malignant Solid Tumors (NCT07700160) | VelaVigo Bio Inc | 2026-07-13 |
| Safety and Efficacy of Multimodal Thermal Therapy (MTT) Combined With KRAS G12V mRNA Vaccine, S-1, and Sintilimab in Patients With Metastatic Pancreatic Cancer (NCT07745790) | Ruijin Hospital | 2026-07-13 |
| Hyperemesis Gravidarum Risk Reduction With Metformin (NCT07129473) | University of Southern California | 2026-07-13 |
| Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants Aged 6 to 23 Months With Moderate-to Severe Atopic Dermatitis (NCT07660835) | Galderma R&D | 2026-07-13 |
| Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (NCT07269470) | M.D. Anderson Cancer Center | 2026-07-13 |
| Study of XNW5004 Tablets in Advanced Prostate Cancer (NCT07730580) | Evopoint Biosciences Inc. | 2026-07-13 |
| Metric-Optimized Spectacle Prescriptions for Children With Down Syndrome (NCT07490444) | Ohio State University | 2026-07-13 |
| A Trial to Assess the Efficacy and Safety of Obinutuzumab in Treating Adults With Minimal Change Disease (MCD) (NCT07710157) | Medical University Innsbruck | 2026-07-13 |
| Selinexor, Daratumumab, and Dexamethasone (XDd) for Light-Chain Cardiac Amyloidosis (NCT07743957) | Beijing Anzhen Hospital | 2026-07-13 |
| A Phase II Study of H021 Enteric-coated Tablets for Moderately to Severely Active Crohn's Disease (NCT07677514) | Jiangsu Carephar Pharmaceutical Co., Ltd. | 2026-07-12 |
| Study Comparing Two Serums With Intense Pulsed Light for the Treatment of Moderate to Severe Photodamage and Crepiness on the Forearms (NCT07686198) | Goldman, Butterwick, Fitzpatrick and Groff | 2026-07-10 |
| Neoadjuvant Short-Course Radiotherapy Plus Tislelizumab and Chemotherapy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma (NCT07678580) | Tang-Du Hospital | 2026-07-10 |
| Study of EV for Recurrent Endometrial Carcinoma (NCT07139977) | William Bradley | 2026-07-10 |
| Luminal Bladder Cancer Effective Response to Neoadjuvant Chemotherapy (LUMBER-NAC) (NCT07762586) | Rutgers, The State University of New Jersey | 2026-07-10 |
| Study of GST-HG131&141 Tablets Compared With Placebo in Patients With Chronic Hepatitis B (NCT07709520) | Fujian Akeylink Biotechnology Co., Ltd. | 2026-07-10 |
| Safety and Efficacy Study of GKL-006RTU in Moderate to Severe Acute Respiratory Distress Syndrome (ARDS) (NCT07706855) | Beijing Gene Key Life Technology Co., Ltd | 2026-07-10 |
| Efficacy of Recombinant Human G-CSF in Women With Unexplained Recurrent Miscarriage (NCT07724405) | Fakih IVF Fertility Center | 2026-07-10 |
| ADAPT Forward 2 - ISA2 - a Study to Evaluate the Safety, Tolerability and Efficacy of Empasiprubart IV Monotherapy in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis (NCT07673627) | argenx | 2026-07-10 |
| Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT): Open Label (NCT07689773) | Medical University of South Carolina | 2026-07-10 |
| A Phase II Study of AK146D1 in Combination With AK112 in Advanced Non-Small Cell Lung Cancer (NCT07669779) | Akeso | 2026-07-10 |
| A Study to Investigate ANS02 in Participants With EGFR Mutation-Positive Non-Small Cell Lung Cancer (NCT07538804) | Avistone Biotechnology Co., Ltd. | 2026-07-10 |
| Eltrombopag Plus Telitacicept vs. Eltrombopag Alone for Steroid-refractory/Relapsed ITP (NCT07687134) | Institute of Hematology & Blood Diseases Hospital, China | 2026-07-10 |
| Efficacy and Safety of Lisaftoclax (APG-2575) Monotherapy in Patients With Mature B-cell Lymphoma (NCT07459608) | Henan Cancer Hospital | 2026-07-10 |
| A Phase II Clinical Trial Evaluating the Efficacy and Safety of SYS6026 Injection in Participants With HPV16 or 18-related High-grade Cervical Squamous Intraepithelial Lesions (NCT07702656) | CSPC Megalith Biopharmaceutical Co.,Ltd. | 2026-07-10 |
| Phase 2 Study Of Mosunetuzumab In Patients With Chronic Lymphocytic Leukemia With Positive MRD (NCT07566364) | M.D. Anderson Cancer Center | 2026-07-09 |
| A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma (NCT07681596) | AstraZeneca | 2026-07-09 |
| Impact of RADA16 Use on Outcomes Following Tonsillectomy in Children (NCT07188779) | Rutgers, The State University of New Jersey | 2026-07-09 |
| A Phase 2 Study to Investigate the Efficacy and Safety of Zelicapavir in Participants Aged ≥28 Days to ≤36 Months of Age Infected With Respiratory Syncytial Virus (NCT07482657) | Enanta Pharmaceuticals, Inc | 2026-07-09 |
| Memory Avoidance Whole Brain Radiotherapy vs Hippocampal Avoidance Whole Brain Radiotherapy (Athena 2 Trial) (NCT07248228) | Case Comprehensive Cancer Center | 2026-07-09 |
| CC-97540 in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis (NCT07388277) | Marcela V. Maus, M.D.,Ph.D. | 2026-07-09 |
| A Mechanistic Study on the Effect of HTD1801 Versus Placebo on Kidney Function in Patients With Type 2 Diabetes and Chronic Kidney Disease. (NCT07496177) | Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences | 2026-07-09 |
| Sequential Gemcitabine Plus Docetaxel Versus Gemcitabine Plus Mitomycin C for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer (NCT07747740) | Blokhin's Russian Cancer Research Center | 2026-07-09 |
| Phosphate in Acute Pancreatitis (NCT07681050) | Duke University | 2026-07-09 |
| Sorfequiline-based Regimens in Adults With Newly Diagnosed Drug-sensitive Pulmonary TB (NCT07672405) | Global Alliance for TB Drug Development | 2026-07-09 |
| Small Trial of Alendronate Impact on the Reservoir of HIV (NCT07216794) | National Institute of Allergy and Infectious Diseases (NIAID) | 2026-07-08 |
| Pilot Study of Prenatal Choline Supplementation (NCT07699393) | Wayne State University | 2026-07-08 |
| A Study to Characterize the Safety and Immunogenicity of AZD6489 in Participants 60 Years of Age and Older (ARIES) (NCT07717840) | AstraZeneca | 2026-07-08 |
| Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors (NCT07599176) | National Heart, Lung, and Blood Institute (NHLBI) | 2026-07-08 |
| Neural Mechanisms of Aerobic Exercise Benefits in PD With DBS (NCT07442747) | The Cleveland Clinic | 2026-07-08 |
| Gut Microbiome and Metabolic Health Study (NCT07457723) | RDC Clinical Pty Ltd | 2026-07-08 |
| Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy (NCT07003295) | National Cancer Institute (NCI) | 2026-07-08 |
| Comparative Evaluation of Sustained meChanical AsPiration Thrombectomy and no Thrombus Modification for Pre-stent Thrombus bUrden Reduction in Patients With Acute Myocardial Infarction Study: the CAPTURE AMI Study (NCT07687576) | Oxford University Hospitals NHS Trust | 2026-07-08 |
| A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis (NCT07516951) | Chiesi Farmaceutici S.p.A. | 2026-07-08 |
| A Phase II/III Study of F520 Combined With Paclitaxel Plus Carboplatin in the Treatment of Cancer of Unknown Primary (CUP) (NCT07761429) | Shandong New Time Pharmaceutical Co., LTD | 2026-07-08 |
| Clinical Trial Evaluating the Safety and Efficacy of Chemoimmunotherapy Plus Short Course of Mek Inhibitor in First Line of Treatment of Metastatic Non Squamous Non Small Cell Lung Adenocarcinoma With PDL1 < 50 %. (NCT05937906) | Centre Georges Francois Leclerc | 2026-07-07 |
| Stem Cells for Erectile Dysfunction Post RALP (NCT07048314) | The Methodist Hospital Research Institute | 2026-07-07 |
| MRD-Guided BCMA/CD3 Bispecific Antibody Treatment After Stem Cell Transplant for Newly Diagnosed Multiple Myeloma (NCT07409454) | Institute of Hematology & Blood Diseases Hospital, China | 2026-07-07 |
| Efficacy and Safety of IPG11406 in Moderately to Severely Active Ulcerative Colitis (Phase 2) (NCT07535489) | Nanjing Immunophage Biotech Co., Ltd | 2026-07-07 |
| APLAUD Trial (Antibiotics vs PLacebo for Acute Uncomplicated Diverticulitis) (NCT07492134) | Vanderbilt University Medical Center | 2026-07-07 |
| Acute Metabolic Effects of Tirzepatide in Type 1 Diabetes (NCT06820281) | Victor Chang Cardiac Research Institute | 2026-07-07 |
| A Study of AK138D1 Alone or in Combination With Ivonescimab in Advanced Non-Small Cell Lung Cancer (NCT07623356) | Akeso | 2026-07-07 |
| Asciminib in HER2+ Breast Cancer Brain Metastases (NCT07136428) | Duke University | 2026-07-07 |
| First-Line Ipilimumab Plus Nivolumab and Nogapendekin Alfa Inbakicept (N-803) in Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer (NCT07355205) | Washington University School of Medicine | 2026-07-07 |
| A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of LRK-4189 Alone and in Combination in Patients With Solid Tumors (NCT07498725) | LARKSPUR BIOSCIENCES, INC. | 2026-07-07 |
| Gene-Modified Stem Cell Therapy for Subjects With Transfusion-dependent Beta-thalassemia (NCT07680803) | Fondazione Telethon | 2026-07-06 |
| Skipping Hormone Therapy in Low-Risk Early Breast Cancer (NCT07661927) | UNICANCER | 2026-07-06 |
| Pucotenlimab Plus Becotatug Vedotin in Perioperative Treatment of Locally Advanced Resectable Head and Neck Squamous Cell Carcinoma (NCT07586124) | Lepu Biopharma Co., Ltd. | 2026-07-06 |
| Comparing DLL3 PET/CT to Standard Scans in Neuroendocrine Cancer (NCT07733024) | Tingting Yuan | 2026-07-06 |
| A Trial to Evaluate the Long-term Safety and Tolerability of HRS-5965 in Patients With Primary IgA Nephropathy (NCT07582133) | Chengdu Suncadia Medicine Co., Ltd. | 2026-07-06 |
| Alzheimer's Tau Platform: Master Protocol (NCT06957418) | Paul S. Aisen | 2026-07-06 |
| Colchicine for the Prevention of Post-Operative Atrial Fibrillation After Coronary Artery Bypass Grafting: A Single-Center, Strategy-Stratified, Randomized, Double-Blind, Placebo-Controlled Trial (NCT07611019) | National Taiwan University Hospital | 2026-07-06 |
| NAI for Sepsis With Persistent Lymphopenia (NCT07578558) | ImmunityBio, Inc. | 2026-07-06 |
| A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer (NCT07349641) | National Cancer Institute (NCI) | 2026-07-06 |
| Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL) (NCT07387926) | Novartis Pharmaceuticals | 2026-07-05 |
| Befotertinib Plus Chemotherapy With an MRD-guided Adaptive Strategy for Treatment Escalation and Response Optimization in EGFR-mutated NSCLC Patients (NCT07709585) | Guangzhou University of Traditional Chinese Medicine | 2026-07-05 |
| Study to Evaluate the Safety and Efficacy of Ublituximab in Participants With Schizophrenia (NCT07680946) | TG Therapeutics, Inc. | 2026-07-03 |
| Dexamethasone, Intravenous Injection of Human Immunoglobulin, and Increased Infusion of Mononuclear Cells to Reduce Donor Specific Antibodies in Haploidentical Hematopoietic Stem Cell Transplantation (NCT07698080) | Hematology department of the 920th hospital | 2026-07-03 |
| Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression (NCT07211438) | Centre for Addiction and Mental Health | 2026-07-03 |
| Enteral Nutrition Versus Standard of Care in Allogeneic Hematopoietic Stem Cell Transplantation (NCT07315165) | University of Nebraska | 2026-07-03 |
| Vebreltinib Plus Furmonertinib in Patients With EGFR-mutated Advanced Non-small Cell Lung Cancer and High PD-L1 Expression (NCT07655622) | Second Affiliated Hospital of Nanchang University | 2026-07-03 |
| "Debridement PhagE AnTibiotics for PJI" (NCT07698002) | Ottawa Hospital Research Institute | 2026-07-02 |
| A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01) (NCT07630974) | Merck Sharp & Dohme LLC | 2026-07-02 |
| Minoxidil With or Without Low-Level Red-Light Therapy for Improving Chemotherapy-Induced Alopecia in Breast Cancer Patients (NCT07594678) | Ohio State University Comprehensive Cancer Center | 2026-07-02 |
| TRACK-TBI Precision Medicine Part 3 - Option II (NCT06790095) | University of California, San Francisco | 2026-07-02 |
| Prevention of Reperfusion Injury Outcomes Through Effective Cardioprotection Targeting Myocardial Infarction (NCT07362446) | Nyrada Pty Ltd | 2026-07-02 |
| Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer (NCT07476287) | Pfizer | 2026-07-02 |
| Melatonin for the Treatment of DEE-SWAS (NCT07221968) | Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | 2026-07-01 |
| Furmonertinib Plus Radiotherapy for EGFR+ NSCLC With Pleural Effusion (NCT07482605) | Jiangmen Central Hospital | 2026-07-01 |
| Oral CBP-0276 or Placebo in Adults With Active Psoriatic Arthritis (PsA) (NCT07706530) | Clarent Biopharma, Inc. | 2026-07-01 |
| Palmitic Acid and Human Microvascular Function (NCT06683534) | Medical College of Wisconsin | 2026-07-01 |
| To Evaluate the Safety and Efficacy of RP902 Tablets (NCT07579884) | Risen (Suzhou) Pharma Tech Co., Ltd. | 2026-07-01 |
| Lumacaftor Yields Reversal of Impaired Cerebral Blood Flow in Heart Failure Patients (NCT07695090) | Qanatpharma AG | 2026-07-01 |
| GI-05: The Impact of Olanzapine Among Patients Receiving Neoadjuvant Chemotherapy for Gastric Cancer (NCT07581405) | University of Illinois at Chicago | 2026-07-01 |